Abstract:

The 2019 coronavirus disease (COVID-19) epidemic caused by SARS-CoV-2 continues to be a major health and economic problem worldwide. Information about how infection affects the liver in children and how chronic liver disease is a risk factor for infection is not yet sufficient. Different treatments for COVID-19 are studied, and some of them are associated with hepatotoxicity. Due to the growing number of patients worldwide, new approaches have begun to be developed to protect those with chronic liver disease from SARS-CoV-2 infection, considering that the risk of severe illness may increase. For this purpose, COVID-19 has also published a special guide for those with chronic liver disease.

Keywords:

Abstract:

The coronavirus disease 2019 (COVID-19) epidemic caused by SARS-CoV-2 continues to be a major health and economic problem worldwide. There is not enough information about how the infection affects the liver in children and chronic liver disease is a risk factor for this infection. Different treatments are being studied for COVID-19, some of which have been linked to hepatotoxicity. Due to the increasing number of patients worldwide, new approaches have been developed to protect those with chronic liver disease from SARS-CoV-2 infection, considering that the risk of severe disease may increase. For this purpose, COVID-19 has also published a special guide for those with chronic liver disease.